Old arthritis drug takes on tough cancers in early trial
Disease control
Recruiting now
This early-phase trial is testing leflunomide, a drug currently used for rheumatoid arthritis, in people with advanced solid tumors that have a PTEN gene change or HER2-negative breast cancer. The study has two parts: first, finding a safe dose and checking for side effects; seco…
Phase: PHASE1 • Sponsor: Deborah Doroshow • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC